A panel of experts has recommended that existing programmes be phased out and that systematic screening programmes be replaced with systematic screening information that would give women the opportunity to make individual choices. Report: Mark Nicholls
A new study has suggested that mammography screening of healthy women can help to significantly reduce deaths from breast cancer. Much will now depend on new treatments and more systematic management of patients. Report: Mark Nicholls
Mammography scans with lower dose and higher contrast – that’s the declared goal of Dr Nik Hauser, Medical Director of the Women‘s Clinic and Director of the Interdisciplinary Breast Centre at Kantonsspital Baden, Switzerland, and Professor Marco Stampanoni of Paul Scherrer Institute in Villigen, Switzerland.
US-American researchers have shown that positron emission tomography (PET), a tried procedure, is a helpful modality to detect breast cancer.
Created by the Dutch industrialist family Hilekes, in 1993 Medicor expanded beyond the Benelux countries to enter the German-speaking world as Medicor Germany GmbH, selling contrast media injectors for CT, MRI and angiography.
Digital breast tomosynthesis offers a number of benefits over other modalities but challenges remain in its optimum clinical application.
Why is early detection of breast cancer so important? Professor Dr Walter Heindel, Director of the Institute of Clinical Radiology at University Hospital Münster, Germany, offers an unequivocal answer.
It may well be the first computer-aided detection (CAD) software that went to school with radiologists to study breast cancer.
In May, 2013, the U.S. Food and Drug Administration (FDA) finally took the training wheels off tomosynthesis by approving the use of Hologic's new C-View 2D imaging in place of conventional 2D mammograms previously required as part of a breast tomosynthesis screening exam.
RSNA opens a window for one week where companies can showcase the latest technologies ahead of regulatory approval. Fujifilm seized this opportunity to introduce the leading edge in tomosynthesis, the Amulet Innovality that it has launched in Europe, and that once given the green light by the FDA will come to America under the name Aspire Cristalle.
With the help of a commercially available CAD (computer-assisted diagnosis) programme, MRI can provide prognostic data on the development of distant metastases in the further course of breast cancer.
Research using an analytical health economics model has suggested the current system of screening within the UK’s National Health Service (NHS) is only moderately likely to be cost effective.
Dr. Paula Martínez Miravete didn’t set out to change breast imaging in Spain when she first adopted breast tomosynthesis.
The movement for interoperability among health information devices and systems has spread across Europe reaching Turkey, which will be host to the European IHE Connectathon in Istanbul this April
New business ventures, new systems – and those include 3-D mammography
With 350,000 mammography screenings annually, Unilabs Sweden finds itself on the leading edge for research in mammography and pioneering patient education programmes. John Brosky reports
A first in medical imaging is still unknown for Kit Vaughan, who is ready to simultaneously scan with X-rays and ultrasound for breast screening. Stay tuned for the results at RSNA 2013, says EH Correspondent John Brosky
Study suggests a new method to measure breast density can help determine cancer risk
Much, if not even everything, may have been said already about the multimodal approach in breast diagnostics. However, Professor Rüdiger Schulz-Wendtland at the Institute of Radiology, University Hospital Erlangen, says there is still surprising news from this field – innovations in multimodal breast diagnostics, for example.
Germany’s mammography screening programme, introduced in 2005, was rolled out across the country in 2009 for women between the ages of 50 and 69 years. The mammo screening coordination office, which heads up and monitors the country’s 94 screening units, has published for the first time an evaluation report with follow-up examinations after a twoyear period.
Magnetic resonance imaging is a long-established, highquality and safe examination tool. Why, therefore, do German gynaecologists and radiologists question its value in breast cancer diagnoses? Indeed the question ‘Breast MRI - yes or no?’ has split the medical community. One ardent champion of breast MRI is Professor Christiane Kuhl MD, director of the diagnostic and interventional radiology…
Breast cancer screening for women between 40 and 49 years – yes or no? This is one of the most controversial issues as this year’s European Congress of Radiology (ECR) in Vienna. For Professor Dr Andy Evans of the Centre for Oncology & Molecular Medicine at the University of Dundee the answer is clear: “Yes. There is good evidence that breast cancer screening for women in their 40s is…
A multi-disciplinary team approach is crucial if healthcare professionals are to offer breast cancer patients the best possible care in the years ahead. That was the opinion voiced by three experts at an ECR 2012 session on Saturday afternoon with delegates addressed by a radiologist, surgeon and an oncologist.
Early this year the radiology and nuclear medicine practice of Doctors Andreas Blynow, Frank Muller, Jorg Kowalski in Ludwigshafen, Germany, began to offer breast examinations using Europe’s first Positron Emission Mammography (PEM) scanner. With 15 years experience with Positron Emission Tomography (PET), Dr Muller introduced the new PEM scanner to the partners’ practice to detect and assess…
Hologic a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, will launch four ready-to-market technologies at the European Congress of Radiology.